Cargando…

Serum oestrogen receptor α and β bioactivity are independently associated with breast cancer: a proof of principle study

BACKGROUND: Oestrogens play a crucial role in breast carcinogenesis. Earlier studies have analysed the serum levels of endogenous hormones measured by conventional assays. In this study, we analysed the capacity of serum from breast cancer cases and controls to transactivate the oestrogen receptor α...

Descripción completa

Detalles Bibliográficos
Autores principales:	Widschwendter, M, Lichtenberg-Frate, H, Hasenbrink, G, Schwarzer, S, Dawnay, A, Lam, A, Menon, U, Apostolidou, S, Raum, E, Stegmaier, C, Jacobs, I J, Brenner, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713696/ https://www.ncbi.nlm.nih.gov/pubmed/19491898 http://dx.doi.org/10.1038/sj.bjc.6605106

Ejemplares similares

Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study
por: Widschwendter, Martin, et al.
Publicado: (2008)

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women
por: Fourkala, Evangelia-Ourania, et al.
Publicado: (2012)

Expression of oestrogen receptor β and prognosis of colorectal cancer
por: Rudolph, A, et al.
Publicado: (2012)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
por: Pedersen, J W, et al.
Publicado: (2013)

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
por: Kameda, C, et al.
Publicado: (2010)

Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment
por: Miller, W R, et al.
Publicado: (2006)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015)

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers
por: Surowiak, P, et al.
Publicado: (2006)

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
por: West, N R, et al.
Publicado: (2013)

17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer
por: Gunnarsson, C, et al.
Publicado: (2005)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis
por: Rosin, G, et al.
Publicado: (2014)

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma
por: Rojo, Federico, et al.
Publicado: (2016)

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
por: Ohotski, J, et al.
Publicado: (2012)

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
por: Fry, Simon A, et al.
Publicado: (2016)

Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression
por: McCarthy, P L, et al.
Publicado: (2008)

NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation
por: Van Laere, S J, et al.
Publicado: (2007)

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
por: Burford, B, et al.
Publicado: (2013)

Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
por: Palmieri, C, et al.
Publicado: (2012)

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
por: Goebel, G, et al.
Publicado: (2012)

Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study
por: Haug, U, et al.
Publicado: (2008)

Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening
por: Tao, S, et al.
Publicado: (2012)

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
por: Müller, H M, et al.
Publicado: (2003)

Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia
por: Haug, U, et al.
Publicado: (2011)

Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis
por: Voorneveld, P W, et al.
Publicado: (2013)

CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma
por: Okabe, H, et al.
Publicado: (2014)

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma
por: Sonobe, M, et al.
Publicado: (2005)

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
por: Seo, A N, et al.
Publicado: (2013)

8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
por: Sova, H, et al.
Publicado: (2010)

Independent and functional validation of a multi-tumour-type proliferation signature
por: Starmans, M H W, et al.
Publicado: (2012)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
por: Choi, Y, et al.
Publicado: (2013)

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
por: West, N P, et al.
Publicado: (2010)

Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an αvβ3-independent manner
por: Edwards, S, et al.
Publicado: (2006)

Tumour-associated CD66b(+) neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
por: Carus, A, et al.
Publicado: (2013)

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
por: Cheng, C-L, et al.
Publicado: (2011)

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014)

Radiation-induced non-targeted response in vivo: role of the TGFβ-TGFBR1-COX-2 signalling pathway
por: Chai, Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7mv9g1omu9kla63607apdh3vq3